期刊文献+

利培酮合并氯氮平与单用利培酮治疗精神分裂症对照观察 被引量:2

The Compared Study of Treating Schizophrenia with Risperidone Combining Clozapine
下载PDF
导出
摘要 目的 评价利培酮合并氯氮平治疗精神分裂症的疗效和副作用。方法 将 40例精神分裂症病人按序贯法随机分配到利培酮合并氯氮平组 ( 2 0例 ) ,单用利培酮组 ( 2 0例 ) ,治疗 8周 ,用简明精神病量表 (BPRS)评定疗效 ,用副反应量表 (TESS)评定副反应。结果 利培酮合并氯氮平组与单用利培酮组之间疗效无显著性差异 ,在缺乏活力因子方面 ,两组间有差异 ,利培酮合并氯氮平组的副反应有活动减少、嗜睡、便秘、唾液增多、心动过速等 ,单用利培酮组的副反应主要是锥体外系反应。结论 利培酮合并中小剂量的氯氮平 ,有助于预防或减少锥体外系反应 。 Objective To evaluate the therapeutic effect and side-effect of treating schizophrenia with Risperidone combining Clozapine.Methods 40 patients with schizophrenia were divided into two groups to carry out a eight week follow up comparative study.The 20 of patients with schizophrenia were treated with Risperidone combining Clozapine as the research group,and the 20 patients with schizophrenia were treated with Risperidone as the control group.The therapeutic effect was assessed by BPRS,Brief Psychiatric Rating Scale.The side effect was assessed by TESS,Treatment Emergent Symptom Scale.Results There was no significant differences between the two groups in the therapeutic effect.There was significant differences between the two groups in the factor of deficiency activity.The reserch group showed these side-effect,activity-reducing,somnolence,constipation,salivation and tachycardia.The control group showed mainly the side-effect of EPS.Conclusions Risperdone combining Clozapine(smaller dosage)can prevent and reduce external pyramid symptom(EPS)and do not lead to another side-effect.
作者 谢聪 倪小玲
出处 《预防医学情报杂志》 CAS 2001年第4期245-246,共2页 Journal of Preventive Medicine Information
关键词 精神分裂症 利培酮 氯氮平 药物疗法 治疗 合并用药 schizophrenia Risperidone Clozapine
  • 相关文献

参考文献7

二级参考文献27

  • 1陈若扬,何金香.重症颅脑损伤患者早期功能锻炼规范化的应用效果研究[J].中国预防医学杂志,2019,20(11):1106-1109. 被引量:8
  • 2[2]Heinrich K,Klieser E,Lehmann E et al.Risperidone versus clozapine in the treatment of schizophrenic patients with acute symptoms.Prog Neuropsychopharmacol Biol Psychiatry,1994; 18:129
  • 3[5]Marder S R,Meibach R C.Risperidone in the treatment of schizophrenia.Am J Psychiary,1994,151:825~835
  • 4[6]Carman J,Peuskens J,Vangeneugden A.Risperidone in the treatment of negative symptoms of schizophrenia.International Clinical Psychopharmacology,1995,10(4):207~213
  • 5[7]Stip E,Lussier I.The effect of risperidone on cognition inpatient with schizophrenia.Canadian Journal of Psychiatry,1996,41(2):35~40
  • 61.Kand J,Honigfeld G,Singer J,et al.Clozapine for the treatment-resistant schizophrenia: a double-blind comparison with chlorpromazine.Arch Gen Psychiatry,1988,45:789
  • 72.Peuskens J.Risperidone in the treatment of patients with chronic schizophrenia: a multi-national,multi-centre,double-blind,parallel-group study versus haloperidol risperidone study group.Br J Psychiatry,1995,166:712
  • 84.Leysen JE,Janssen PMF,Megens AAHP,et al.Risperidone: a novel antipsychotic balanced serotonin-dopamine antagonism,receptor occupancy profile,and pharmacologic activity.J Clin Psychiatry,1994,55:5
  • 95.Bondolfi G,Dufour H,Patris M,et al.Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a tandomized double-blind study.Am J Psychiatry,1998,155:499
  • 10于欣,侯也之,舒良,王秀玲,李冰,刘卫红,林凯,杨顺才,宋丽华,廖安燕,谢家康,贾宏晓,张继志.利培酮治疗精神分裂症的开放性临床验证[J].中华精神科杂志,1997,30(2):79-82. 被引量:330

共引文献181

同被引文献12

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部